> In plaque psoriasis studies, the safety of TALTZ  in combination with other immunomodulatory agents or phototherapy has not been evaluated.  In population pharmacokinetic analyses , clearance of ixekizumab was not affected by concomitant administration of oral CORTICOSTEROIDS, NSAIDs, SULFASALAZINE,  or METHOTREXATE. 
